Showing results (681-690 of 2,441) with videos related to

Sort By:
Pageof 245
Clinical and Translational Science|November 18, 2021
Fear and food: Anxiety-like behavior and the susceptibility to weight loss in an activity-based anorexia rat modelConstanze Schwenzer, Clara Voelz, Vanessa Kogel, et al.
Clinical and Translational Science|December 10, 2021
Optimizing moxidectin dosing for Strongyloides stercoralis infections: Insights from pharmacometric modelingDaniela Hofmann, Cornelis Smit, Somphou Sayasone, et al.
Clinical and Translational Science|October 25, 2022
Muscle velocity recovery cycles as pharmacodynamic biomarker: Effects of mexiletine in a randomized double-blind placebo-controlled cross-over studyTitia Q Ruijs, Ingrid W Koopmans, Marieke L de Kam, et al.
Clinical and Translational Science|November 4, 2022
The vaccine hesitancy continuum among hesitant adopters of the COVID-19 vaccineRamey Moore, Rachel S Purvis, Don E Willis, et al.
Clinical and Translational Science|November 5, 2022
ST2 and CSF-1 as potential druggable targets of inflammatory bowel diseases: Results from two-sample Mendelian randomization studyJiarui Mi, Xia Wu, Xiaoyin Bai, et al.
Clinical and Translational Science|October 6, 2022
Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulationGiovanna Petrucci, Alberto Giaretta, Paola Ranalli, et al.
Clinical and Translational Science|October 7, 2022
Population-based cellular kinetic characterization of ciltacabtagene autoleucel in subjects with relapsed or refractory multiple myelomaLiviawati S Wu, Yaming Su, Claire Li, et al.
Clinical and Translational Science|September 1, 2022
Regulatory variants in a novel distal enhancer regulate the expression of CYP3A4 and CYP3A5Joseph M Collins, Adaeze C Nworu, Somayya J Mohammad, et al.
Clinical and Translational Science|December 27, 2021
A phase I, randomized, double-blind, placebo-controlled, single- and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX-128, a highly selective Nav 1.8 inhibitor, in healthy adultsHemme J Hijma, Emilie M J van Brummelen, Pieter S Siebenga, et al.
Clinical and Translational Science|September 30, 2022
Design and conduct considerations for studies in patients with hepatic impairmentPaulien Ravenstijn, Manoranjenni Chetty, Pooja Manchandani, et al.
Pageof 245